$KMDA SEC Filings

Filed On	Filing
06 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
05 Oct 2026	REPORT OF FOREIGN PRIVATE ISSUER
29 Sep 2026	Form 4: Asher-Topilsky Lilach, Director Granted 86,500 Employee Stock Option (right to buy)
29 Sep 2026	Form 4: Davidi Ishay, Director Granted 86,500 Employee Stock Option (right to buy)
29 Sep 2026	Form 4: Botzer Uri, Director Granted 60,000 Employee Stock Option (right to buy)
25 Sep 2026	Form 4: London Amir, Chief Executive Officer Granted 800,000 Employee Stock Option (right to buy)
24 Sep 2026	Form 4: Gorelik Boris, VP, BD and Strategic Programs Granted 15,000 Employee Stock Option (right to buy)
24 Sep 2026	Form 4: Payorski Lilach, Director Granted 60,000 Employee Stock Option (right to buy)
24 Sep 2026	Form 4: Reshef Liron, VP Human Resources Granted 100,000 Employee Stock Option (right to buy)
24 Sep 2026	Form 4: Goldwasser Karnit, Director Granted 86,500 Employee Stock Option (right to buy)
24 Sep 2026	Form 4: Beladev Shavit, VP Plasma Operations Granted 75,000 Employee Stock Option(right to buy)
23 Sep 2026	Form 4: Nir Eran, VP, Operations Granted 112,500 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Itshayek Assaf, Director Granted 46,000 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Dekel Benjamin, Director Granted 46,000 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Neheman Hanni, VP, Marketing & Sales Granted 75,000 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Livneh Nir, VP, General Counsel Granted 89,485 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Pinchuk Orit, VP Regulatory Affairs Granted 75,000 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Recanati Leon, Director Granted 86,500 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Orlev Chaime, Chief Financial Officer Granted 202,500 Employee Stock Option (right to buy)
23 Sep 2026	Form 4: Brenner Yael, VP Quality Granted 60,000 Employee Stock Option (right to buy)

Comments